Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,344 | -59,607 | -49,823 | -34,045 | -15,334 |
| Depreciation Amortization | 120 | 373 | 354 | 298 | 183 |
| Other Working Capital | 2,948 | 4,276 | 4,330 | 1,900 | -902 |
| Other Operating Activity | -1,991 | 6,754 | 4,850 | 1,439 | -235 |
| Operating Cash Flow | $-5,267 | $-48,204 | $-40,289 | $-30,408 | $-16,288 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 7,125 | N/A | N/A | N/A |
| Common Stock Issued | 413 | 100 | 47 | 47 | N/A |
| Common Stock Repurchased | -289 | -897 | N/A | N/A | -366 |
| Other Financing Activity | -14 | -52 | -484 | -478 | -29 |
| Financing Cash Flow | $110 | $6,276 | $-437 | $-431 | $-395 |
| Beginning Cash Position | 7,118 | 49,046 | 49,046 | 49,046 | 49,046 |
| End Cash Position | 1,961 | 7,118 | 8,320 | 18,207 | 32,363 |
| Net Cash Flow | $-5,157 | $-41,928 | $-40,726 | $-30,839 | $-16,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,267 | -48,204 | -40,289 | -30,408 | -16,288 |
| Free Cash Flow | -5,267 | -48,204 | -40,289 | -30,408 | -16,288 |